Cite
HARVARD Citation
Ladetto, M. et al. (2021). Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial. Lancet. 8 (1), pp. e34-e44. [Online].